Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – In patients with cystic fibrosis frequently treated for chronic Pseudomonas aeruginosa infection, aztreonam lysine for inhalation may be an effective add-on therapy, researchers…
NEW YORK (Reuters Health) – A study of Vietnam War era veterans shows that exposure to Agent Orange is associated with a significantly increased risk of prostate cancer,…
NEW YORK (Reuters Health) – Contrary to widespread recommendations, early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy, results of a study…
NEW YORK (Reuters Health) – Symptoms of posttraumatic stress disorder (PTSD) appear to increase the long-term mortality rate in patients with implantable cardioverter defibrillators (ICDs), according to a…
NEW YORK (Reuters Health) – In children at heightened risk for atopy, common childhood immunization is not associated with an increased risk of more severe eczema or allergic…
NEW YORK (Reuters Health) – In patients with unstable type 1 diabetes, hypoglycemia awareness — which often deteriorates over time — can be enhanced with islet transplantation, new…
Jan Brooks, a Together Rx Access cardholder, discusses her experience using the Together Rx Access program to save on prescription medication for her family. Most cardholders save 25%-40%…
NEW YORK (Reuters Health) – Once elderly patients are diagnosed with Alzheimer’s disease, ethnicity and comorbidity appear to affect survival, investigators report in the November 4 issue of…
NEW YORK (Reuters Health) – Postmenopausal women with hypoactive sexual desire disorder reported improved sexual function when treated with transdermal testosterone, in a clinical trial reported in the…
Dr. Robin Felder, PhD, Professor and Associate Director of Clinical Chemistry and Toxicology at the University of Virginia Health System, talks about the latest developments in regenerative medicine…
